XML 47 R32.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS' EQUITY (Tables)
6 Months Ended
Jun. 30, 2025
STOCKHOLDERS' EQUITY  
Schedule of Stock option activity

    

    

    

    

Weighted

    

Weighted

average

average

remaining

Aggregate

exercise

contractual

Intrinsic

Number of

price

life

value

options

$

Years

$

Options outstanding at beginning of period

 

10,222,749

2.78

8.55

9

Options granted

 

1,360,950

0.77

Options exercised

 

-

Options expired

 

(797,216)

5.14

Options forfeited

 

(1,227,965)

1.50

Options outstanding at end of period

 

9,558,518

2.46

8.38

5

Options vested and expected to vest at end of period

 

7,484,313

2.50

8.31

3

Exercisable at end of period

 

3,935,650

4.29

7.19

4

Schedule of Restricted Stock option activity

Number of

Restricted shares

Restricted shares outstanding at beginning of year

 

5,408,404

Restricted shares granted

 

1,525,300

Restricted shares forfeited

 

(66,504)

Restricted shares outstanding at end of period

 

6,867,200

Schedule of assumptions used to estimate the fair values of the options granted to employees, directors and non-employees

Six months ended

 

June 30, 

 

    

2025

2024

 

Volatility

 

96.72-102.19

%

94.75-97.97

%

Risk-free interest rate

 

4.08-4.23

%  

3.85-4.72

%

Dividend yield

 

%

%

Expected life (years)

 

5.00-5.87

5.00-5.87

Schedule of Compensation cost

Three months ended

June 30, 

    

2025

    

2024

Cost of revenues

$

6

$

5

Research and development

 

441

 

448

Sales and marketing

 

583

 

1,650

General and administrative

 

1,005

 

1,459

Total stock-based compensation expenses

$

2,035

$

3,562

Six months ended

June 30, 

    

2025

    

2024

Cost of revenues

$

16

$

12

Research and development

 

966

 

1,563

Sales and marketing

 

1,398

 

3,406

General and administrative

 

1,997

 

5,439

Total stock-based compensation expenses

$

4,377

$

10,420